FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3097249531> ?p ?o ?g. }

• W3097249531 abstract "There is popular and bipartisan support for legalizing the importation of lower-cost medicines from Canada to help reduce the high prescription drug costs that Americans pay. Despite the wide interest in this policy, attempts over the last sixteen years to create a formal system for large-scale prescription drug importation in the United States have failed. The Trump administration recently issued a Notice of Proposed Rulemaking to enable the legal importation of prescription drugs from Canada, but the Notice has important design flaws and seems destined to suffer a similar fate as previous efforts.In this article, we argue that prescription drug importation is a form of international regulatory engagement that can work, but not in the manner that recent congressional legislation or the Trump administration has proposed. Importation of prescription drugs, even foreign versions of already-approved drugs, requires the importing nation to accept the marketing approval standards, processes, and product-specific decisions of the exporting nation as equivalent to domestic regulation. The FDA, however, has made far fewer determinations of foreign regulatory equivalence than its counterpart regulators. As a result, the statutory requirements for the FDA maintaining direct oversight over prescription drug imports from Canada are onerous and unlikely ever to be fulfilled.Examining U.S. prescription drug importation as a form of reliance on the equivalence of foreign regulation is, as far as we can determine, a novel inquiry, and it offers useful insights. Foreign equivalence determinations have been successfully used in pharmaceutical regulation in two contexts: (1) trade initiatives and (2) circumstances in which regulatory agencies were unable to fulfill their core institutional mandates without relying on the decision-making of their foreign counterparts. The FDA has not fit neatly into either of these contexts. In contrast to many of its foreign counterparts, the FDA has consolidated authority over pharmaceutical regulation, which it sustains through its reputation among its constituents—appropriators, consumers, pharmaceutical product sponsors, and the relevant medical and scientific communities— for overseeing the safety, efficacy, and quality of medicines. The FDA has resisted risking any harm to that gatekeeper reputation that might follow from its pursuit of other policy objectives, such as lowering drug prices or facilitating trade. Furthermore, FDA officials describe themselves as “the gold standard” for drug review—more thorough and rigorous about regulation than their counterparts—and, until recently, as able to fulfill their core institutional mandates without the cooperation of foreign counterpartsBased on this analysis of the political economy of pharmaceutical regulation and international regulatory cooperation at the FDA, we propose that U.S. prescription drug importation could be successfully used to address generic drug shortages, a persistent regulatory problem that the FDA has been unable to solve independently. We argue that the same analysis can help identify other circumstances when the FDA might usefully engage foreign counterparts, such as foreign manufacturer inspections for the rapidly increasing volume of U.S. drug imports, the growing complexity of global pharmaceutical supply chains, and the technological advances in personalized medicines." @default.
• W3097249531 created "2020-11-09" @default.
• W3097249531 creator A5030814303 @default.
• W3097249531 creator A5074257304 @default.
• W3097249531 date "2020-07-17" @default.
• W3097249531 modified "2023-09-23" @default.
• W3097249531 title "Reputation and Authority: The FDA and the Fight over U.S. Prescription Drug Importation" @default.
• W3097249531 hasPublicationYear "2020" @default.
• W3097249531 type Work @default.
• W3097249531 sameAs 3097249531 @default.
• W3097249531 citedByCount "0" @default.
• W3097249531 crossrefType "posted-content" @default.
• W3097249531 hasAuthorship W3097249531A5030814303 @default.
• W3097249531 hasAuthorship W3097249531A5074257304 @default.
• W3097249531 hasConcept C100001284 @default.
• W3097249531 hasConcept C144133560 @default.
• W3097249531 hasConcept C158129432 @default.
• W3097249531 hasConcept C162324750 @default.
• W3097249531 hasConcept C17744445 @default.
• W3097249531 hasConcept C190253527 @default.
• W3097249531 hasConcept C199539241 @default.
• W3097249531 hasConcept C2426938 @default.
• W3097249531 hasConcept C2776396487 @default.
• W3097249531 hasConcept C2777351106 @default.
• W3097249531 hasConcept C2778858636 @default.
• W3097249531 hasConcept C2779913896 @default.
• W3097249531 hasConcept C2780035454 @default.
• W3097249531 hasConcept C2781019588 @default.
• W3097249531 hasConcept C71924100 @default.
• W3097249531 hasConcept C98274493 @default.
• W3097249531 hasConceptScore W3097249531C100001284 @default.
• W3097249531 hasConceptScore W3097249531C144133560 @default.
• W3097249531 hasConceptScore W3097249531C158129432 @default.
• W3097249531 hasConceptScore W3097249531C162324750 @default.
• W3097249531 hasConceptScore W3097249531C17744445 @default.
• W3097249531 hasConceptScore W3097249531C190253527 @default.
• W3097249531 hasConceptScore W3097249531C199539241 @default.
• W3097249531 hasConceptScore W3097249531C2426938 @default.
• W3097249531 hasConceptScore W3097249531C2776396487 @default.
• W3097249531 hasConceptScore W3097249531C2777351106 @default.
• W3097249531 hasConceptScore W3097249531C2778858636 @default.
• W3097249531 hasConceptScore W3097249531C2779913896 @default.
• W3097249531 hasConceptScore W3097249531C2780035454 @default.
• W3097249531 hasConceptScore W3097249531C2781019588 @default.
• W3097249531 hasConceptScore W3097249531C71924100 @default.
• W3097249531 hasConceptScore W3097249531C98274493 @default.
• W3097249531 hasLocation W30972495311 @default.
• W3097249531 hasOpenAccess W3097249531 @default.
• W3097249531 hasPrimaryLocation W30972495311 @default.
• W3097249531 hasRelatedWork W104789671 @default.
• W3097249531 hasRelatedWork W1579249821 @default.
• W3097249531 hasRelatedWork W1689133548 @default.
• W3097249531 hasRelatedWork W1858787615 @default.
• W3097249531 hasRelatedWork W2018595052 @default.
• W3097249531 hasRelatedWork W2399721877 @default.
• W3097249531 hasRelatedWork W2413801867 @default.
• W3097249531 hasRelatedWork W2801266183 @default.
• W3097249531 hasRelatedWork W2935742803 @default.
• W3097249531 hasRelatedWork W2969137655 @default.
• W3097249531 hasRelatedWork W3122157063 @default.
• W3097249531 hasRelatedWork W3125515911 @default.
• W3097249531 hasRelatedWork W3158072262 @default.
• W3097249531 hasRelatedWork W3162845278 @default.
• W3097249531 hasRelatedWork W3177665412 @default.
• W3097249531 hasRelatedWork W343415374 @default.
• W3097249531 hasRelatedWork W569817311 @default.
• W3097249531 hasRelatedWork W67130921 @default.
• W3097249531 hasRelatedWork W749948069 @default.
• W3097249531 hasRelatedWork W1856877923 @default.
• W3097249531 isParatext "false" @default.
• W3097249531 isRetracted "false" @default.
• W3097249531 magId "3097249531" @default.
• W3097249531 workType "article" @default.